If you’re dealing with depression or anxiety, relief can sometimes be hard to find. At Sunrise Psychiatry Inc, Dr. Sonni ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
Postpartum depression affects many new mothers, increasing suicide risk. New research shows preventive cognitive behavioral ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).